These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
540 related articles for article (PubMed ID: 12823641)
1. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. Vgontzas AN; Bixler EO; Chrousos GP J Intern Med; 2003 Jul; 254(1):32-44. PubMed ID: 12823641 [TBL] [Abstract][Full Text] [Related]
2. Sleep apnea is a manifestation of the metabolic syndrome. Vgontzas AN; Bixler EO; Chrousos GP Sleep Med Rev; 2005 Jun; 9(3):211-24. PubMed ID: 15893251 [TBL] [Abstract][Full Text] [Related]
3. Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance? Vgontzas AN Arch Physiol Biochem; 2008 Oct; 114(4):211-23. PubMed ID: 18946782 [TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. Vgontzas AN; Legro RS; Bixler EO; Grayev A; Kales A; Chrousos GP J Clin Endocrinol Metab; 2001 Feb; 86(2):517-20. PubMed ID: 11158002 [TBL] [Abstract][Full Text] [Related]
5. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. Vgontzas AN; Papanicolaou DA; Bixler EO; Hopper K; Lotsikas A; Lin HM; Kales A; Chrousos GP J Clin Endocrinol Metab; 2000 Mar; 85(3):1151-8. PubMed ID: 10720054 [TBL] [Abstract][Full Text] [Related]
6. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea. Vgontzas AN; Trakada G; Bixler EO; Lin HM; Pejovic S; Zoumakis E; Chrousos GP; Legro RS Metabolism; 2006 Aug; 55(8):1076-82. PubMed ID: 16839844 [TBL] [Abstract][Full Text] [Related]
7. Selective effects of CPAP on sleep apnoea-associated manifestations. Vgontzas AN; Zoumakis E; Bixler EO; Lin HM; Collins B; Basta M; Pejovic S; Chrousos GP Eur J Clin Invest; 2008 Aug; 38(8):585-95. PubMed ID: 18627419 [TBL] [Abstract][Full Text] [Related]
8. Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome. Tasali E; Van Cauter E; Ehrmann DA J Clin Endocrinol Metab; 2006 Jan; 91(1):36-42. PubMed ID: 16219719 [TBL] [Abstract][Full Text] [Related]
9. Obstructive sleep apnoea and polycystic ovary syndrome: A comprehensive review of clinical interactions and underlying pathophysiology. Kahal H; Kyrou I; Tahrani AA; Randeva HS Clin Endocrinol (Oxf); 2017 Oct; 87(4):313-319. PubMed ID: 28640938 [TBL] [Abstract][Full Text] [Related]
10. Impact of sleep-disordered breathing on metabolic dysfunctions in patients with polycystic ovary syndrome. Chatterjee B; Suri J; Suri JC; Mittal P; Adhikari T Sleep Med; 2014 Dec; 15(12):1547-53. PubMed ID: 25311833 [TBL] [Abstract][Full Text] [Related]
12. A Study to Evaluate the Effect of Body Mass Index on the Prevalence of Sleep-Disordered Breathing in Adult Patients with Metabolic Syndrome. Sehgal IS; Dhooria S; Virdi S; Agarwal R; Chaudhry D Indian J Chest Dis Allied Sci; 2016 Jul; 58(3):177-181. PubMed ID: 30152651 [TBL] [Abstract][Full Text] [Related]
13. Metabolic alterations in adolescents with obstructive sleep apnea. Bhushan B; Ayub B; Loghmanee DA; Billings KR Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2368-73. PubMed ID: 26581829 [TBL] [Abstract][Full Text] [Related]
17. Obesity-related sleepiness and fatigue: the role of the stress system and cytokines. Vgontzas AN; Bixler EO; Chrousos GP Ann N Y Acad Sci; 2006 Nov; 1083():329-44. PubMed ID: 17148748 [TBL] [Abstract][Full Text] [Related]
18. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Gruber A; Horwood F; Sithole J; Ali NJ; Idris I Cardiovasc Diabetol; 2006 Nov; 5():22. PubMed ID: 17078884 [TBL] [Abstract][Full Text] [Related]
19. Sleep-disordered breathing in obese children is associated with prevalent excessive daytime sleepiness, inflammation, and metabolic abnormalities. Tsaoussoglou M; Bixler EO; Calhoun S; Chrousos GP; Sauder K; Vgontzas AN J Clin Endocrinol Metab; 2010 Jan; 95(1):143-50. PubMed ID: 19926716 [TBL] [Abstract][Full Text] [Related]
20. Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome. Nandalike K; Agarwal C; Strauss T; Coupey SM; Isasi CR; Sin S; Arens R Sleep Med; 2012 Dec; 13(10):1307-12. PubMed ID: 22921588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]